HOME > BUSINESS
BUSINESS
- Antibody Market to Reach 2.6 Trillion Yen in 2034: Fuji Keizai
June 9, 2025
- Moderna Files Updated Spikevax for LP.8.1 Strain in Japan
June 9, 2025
- Fuso Takes Remitch Patent Case to Top Court
June 9, 2025
- Japan Ethical Drug Sales Up 1.2% in April: Crecon
June 9, 2025
- Takeda Rolls Out AI Tool to Guide “Next Best Action” in Sales
June 6, 2025
- Meiji, Daito to Launch Talks on New Consortium to Stabilize Generic Supply, Boost Profitability
June 6, 2025
- Keytruda Japan’s Top-Selling Drug for 20th Month Running: Encise
June 6, 2025
- Santen’s Myopia Drug Approved in Europe
June 6, 2025
- Towa/CiRA to Launch PII/III Trial of Bromocriptine for Familial AD
June 5, 2025
- Fuji Keizai Issues 2040 Market Outlook for Dermatology, Collagen Diseases and More
June 5, 2025
- Takeda’s Adcetris Widens Label in Europe
June 5, 2025
- Enhertu Entering New Phase of Growth with Early-Line Breast Cancer Data: CEO
June 4, 2025
- Sawai Cuts FY2024 Results after Remitch Ruling, Net Profit Drops by Half
June 4, 2025
- Dupixent’s COPD Use Expected to Benefit Patients with Allergic Symptoms: Professor
June 3, 2025
- Kaken to Codevelop TWOCELLS’ Cell Therapy in Japan
June 3, 2025
- Taiho Out-Licenses LSD1 Inhibitor to Yokohama Upstart
June 3, 2025
- Nxera-Lilly Collab Hits Key Milestone, Triggers Undisclosed Payment
June 3, 2025
- Enhertu Extends Survival as 2nd-Line Gastric Cancer Therapy
June 3, 2025
- Kura/Kyowa Kirin’s AML Drug Accepted for US FDA Review
June 3, 2025
- Fuso Sets Up 8 Billion Yen Credit Line after Remitch Ruling
June 3, 2025
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
